Health Headlines: FDA Dosing Risks, Brazil's Poultry Comeback, Abbott's Legal Drama

Key health news: U.S. FDA warns of dosing risks with Novo Nordisk's weight-loss drug versions, Brazil ends Newcastle disease outbreak in poultry, and Abbott Laboratories ordered to pay $495 million in damages linked to infant formula. The Brazilian Agriculture Ministry awaits removal of trade embargoes.

In a recent development, the U.S. Food and Drug Administration (FDA) alerted both doctors and patients about the dangers of dosing errors related to compounded versions of Novo Nordisk's weight-loss and diabetes medications. Reports indicate adverse events, some severe enough to necessitate hospitalization, are linked to incorrect self-administration of these drugs and healthcare providers' dose miscalculations.

Meanwhile, Brazil's government celebrated the conclusion of a Newcastle disease outbreak in poultry, which had previously halted its poultry exports. Authorities have now informed the World Organization for Animal Health and are waiting for trade partners to lift existing embargoes, per the Agriculture Ministry's announcement.

In legal news, a jury determined that Abbott Laboratories' specialized infant formula led to a severe bowel disease in a premature Illinois girl, resulting in a $495 million damages verdict. This case marks the first of many similar claims slated for trial across the United States.

(With inputs from agencies.)